NSCLC: delayed adjuvant chemotherapy still yields benefit

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • Patients with NSCLC may continue to benefit from adjuvant chemotherapy even when it is administered beyond the traditional postoperative window.
Why this matters
  • In appropriate patients, physicians should consider chemotherapy up to 4 mo after surgery if patients are able to tolerate it.
  • ...